Clinical Trials Logo

Ileostomy - Stoma clinical trials

View clinical trials related to Ileostomy - Stoma.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06394115 Completed - Ileostomy - Stoma Clinical Trials

Assessment of Novel Technology to Facilitate Drainage in Ostomy Pouches: OUTFLOW Study

OUTFLOW
Start date: August 1, 2022
Phase:
Study type: Observational

The overall aim of this study is to determine the performance and safety of a novel coated material inside Convatec Ostomy Pouches, and to explore the clinical and quality of life benefits that may occur with the use of the test product. A minimum of 30 subjects, and a maximum of 40 subjects will be recruited to obtain 30 complete datasets comprised of a minimum of 15 colostomy and minimum of 10 ileostomies.

NCT ID: NCT05891041 Completed - Ileostomy - Stoma Clinical Trials

New Method for the Collection of the Output From the Ileostoma Using a Intestinal Tampon

Start date: April 26, 2023
Phase:
Study type: Observational

1 study: A pilot study of 8 adults with ileostomy was included in this trial of "first in human" with InterPoc™, an absorbent intestinal tampon safety and feasibility in humans with ileostomies. Study 2: A study in total with 24 participants, evaluating both the safety but also the functionality of InterPoc in humans with ileostomies.

NCT ID: NCT05680428 Completed - Ileostomy - Stoma Clinical Trials

Early Feeding Versus Conventional Feeding

Start date: January 10, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare early feeding vs conventional feeding after stoma reversal. The main question it aims to answer are: • whether it is beneficial to start oral feeding within 12hrs after stoma reversal Participants will be randomly assigned two groups either early feeding or conventional group

NCT ID: NCT05289765 Completed - Ileostomy - Stoma Clinical Trials

Efficacy of Gel With Ecological Extra Virgin Olive Oil in Peristomal Skin Hygiene

gAOVEstoma
Start date: February 22, 2022
Phase: N/A
Study type: Interventional

To evaluate the efficacy of the application of a neutral gel based on ecological extra virgin olive oil for peristomal skin hygiene in individuals with colostomy and ileostomy.

NCT ID: NCT05200416 Completed - Ileostomy - Stoma Clinical Trials

Investigation of Heylo, a Novel App Driven Digital Supporting Ostomy Product

Start date: January 13, 2022
Phase: N/A
Study type: Interventional

People with intestinal stomas can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively. To overcome this, Coloplast has developed a new supporting ostomy product called Heylo™, which has an adhesive sensor layer that should be placed underneath the baseplate. The sensor layer consists of an electronic sensor system that continuously detects moisture and output leakage underneath the baseplate. A transmitter connected to the sensor layer continuously evaluates the incoming information and sends a status to a smartphone software application, which based on a predefined flow decides which information to deliver to the user about the baseplate status. The overall aim of this clinical investigation is to evaluate the benefits of the new supporting product, Heylo compared to Standard of Care.

NCT ID: NCT05048329 Completed - Ileostomy - Stoma Clinical Trials

The Cascade Feasibility Pilot (Ileostomy)

Start date: August 9, 2021
Phase: N/A
Study type: Interventional

Existing interventions including improving communication and self-care to improve readmission of patients undergoing high risk colorectal surgery involving new ileostomy formation has shown limited results. Our proposal is to deploy a wearable solution that predicts physiological perturbation with continuous remote patient monitoring and advanced machine learning algorithms which will be connected to structured, cascading, escalation pathways and care coordination involving home health nurses, colorectal and ostomy nurses, and colorectal surgeons, and has the potential to transform surgical management in the post-discharge period, where patients are the most vulnerable for readmission. This feasibility study will contribute to the understanding of post-discharge continuous remote monitoring of ileostomy patients, promote patient self-care, and has the potential of improving patient outcomes.

NCT ID: NCT04606004 Completed - Clinical trials for Postoperative Complications

Perianal Maceration in Pediatric Ostomy Closure Patients

Start date: November 24, 2020
Phase: N/A
Study type: Interventional

This pilot study will explore whether preoperative application of stool from the stoma bag to the perianal area will prevent/ decrease postoperative perianal maceration in pediatric ostomy closure patients. It will also explore the overall safety and feasibility of this pilot study for larger randomized control trials. There will be a control group and an intervention group. The intervention group will apply stool from the stoma bag approximately 4 weeks prior to ostomy closure and fill out a compliance log and upload pictures weekly to the MyCHP (My Children's Hospital) portal. A validated diaper dermatitis score will be utilized in this study.

NCT ID: NCT04169425 Completed - Ileostomy - Stoma Clinical Trials

Laparoscopic Surgery of Rectal Cancer and Ileostomy

Start date: January 2, 2012
Phase:
Study type: Observational

Elective diverting ileostomy may reduce consequences of anastomotic failure in laparoscopic TME. Aiming to evaluate the effectiveness of elective diverting ileostomy, its impact on the incidence and clinical behavior of anastomotic leakage and the complications related to its presence and take down were analyzed.

NCT ID: NCT04113928 Completed - Ileostomy - Stoma Clinical Trials

Broccoli Ileo Study

Start date: March 23, 2015
Phase: N/A
Study type: Interventional

Epidemiological and experimental studies have indicated that the consumption of diets rich in cruciferous vegetables such as broccoli has a range of beneficial effects on human health. These effects are usually attributed to naturally-occurring glucosinolates and their breakdown products, isothiocyanates, in cruciferous vegetables. One of these compounds, sulforaphane, the hydrolysis product of glucoraphanin, the main glucosinolate in broccoli has been reported to have bactericidal activity against H. pylori and other human pathogens. The investigators have recently shown that adding mustard seeds, which contain a more resilient form of this enzyme, to processed broccoli actually increased the formation of sulforaphane and minimised production of another biologically-inactive form. Experimental studies by the investigators have shown that sulforaphane can inhibit growth of a number of enteric pathogens including salmonella and E. coli which exert their effects in the small intestine. Currently the bioavailability, stability and bioactivity of sulforaphane in the small intestine of a human following consumption of broccoli is not known. To assess the effect of broccoli phytochemicals in vivo 20 participants who have previously had an ileostomy (removal of colon, > 1.5 years post operative) will be fed 200 ml of broccoli soup/control in a randomised double blind crossover design and collect the ileal fluid before (0 hr) and after (4 hr) the feeding. The ileal fluid collected from participants will have undergone in vivo digestion, allowing analysis of the chemical composition and bioactivity of the ileal fluid. The hypothesis to be tested is that consumption of cooked broccoli plus myrosinase from mustard seeds will result in high levels of sulforaphane in ileostomy fluid, sufficient to suppress growth of enteric pathogens. This study will be used to assess whether previous observations on the in vitro antibacterial activity of broccoli are relevant in vivo.

NCT ID: NCT03770078 Completed - Ileostomy - Stoma Clinical Trials

Assessment of New Enhanced Ostomy Device in Real-life Settings in Subjects Having a Stoma

Start date: November 12, 2018
Phase: N/A
Study type: Interventional

The study investigates the performance of a new adhesive with regard to the skin condition